SCHEMBL6602316

SCHEMBL6602316

COc1nn(-c2ccc(NC(=O)c3ccc(C(F)(F)F)cc3F)cc2)c(=O)o1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.64
LIPC P11150 1/20 0.64
LIPE Q05469 1/20 0.64
ABHD16A O95870 1/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.47
GPR27 Q9NS67 2/20 0.46
TRPV4 Q9HBA0 1/20 0.45
NR3C1 P04150 2/20 0.44
TRPC1 P48995 1/20 0.43
TRPC3 Q13507 1/20 0.43
STIM1 Q13586 1/20 0.43
ORAI1 Q96D31 1/20 0.43
AURKA O14965 1/20 0.43
MGLL Q99685 3/20 0.43
FAAH O00519 2/20 0.43
TRPV1 Q8NER1 1/20 0.42
DHODH Q02127 1/20 0.41
SORT1 Q99523 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604889 0.84 LPL (0.72) LPLLIPCLIPEABHD16AORAI1
SCHEMBL6600553 0.84 LPL (0.62) LPLLIPCLIPEABHD16AMGLL
SCHEMBL6602937 0.79 ABHD16A (0.60) LPLLIPCLIPEABHD16ANR3C1
SCHEMBL7047919 0.79 LPL (1.00) LPLLIPCLIPEABHD16AMGLL
SCHEMBL7042468 0.78 LPL (0.60) LPLLIPCLIPEABHD16AMGLL
SCHEMBL6604642 0.77 LPL (0.62) LPLLIPCLIPEABHD16APTGDR2
SCHEMBL6603513 0.74 LPL (0.64) LPLLIPCLIPEABHD16APTGDR2
SCHEMBL6601943 0.74 LPL (0.72) LPLLIPCLIPEABHD16AORAI1
SCHEMBL15917677 0.73 NPC1 (0.58) PTGDR2GPR27TRPV4TRPV1
SCHEMBL7044266 0.73 LPL (0.70) LPLLIPCLIPEABHD16APTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263745-B1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE AVENTIS PHARMA GMBH (DE) 2004-05-19 EP disclosed